JOURNAL OF CHEMICAL RESEARCH 2009 85
2-(4-Methoxyphenyl)imidazo[1,2-a]pyridine (3b): White solid,
m.p. 135–136°C (lit.28 133–134°C); IR Q (cm-1): 2961, 2838, 1612,
1548, 1482, 1371, 1285, 1244, 1175, 1110, 1077, 1030, 924, 838,
743, 631, 536, 446. 1H NMR: G 8.09 (d, J = 6.77 Hz, 1H), 7.89 (dd,
J = 1.95, 1.94 Hz, 2H), 7.77 (s, 1H), 7.61 (d, J = 9.08 Hz, 1H),
7.17–7.15 (m, 1H), 6.97 (dd, J = 1.97, 1.94 Hz, 2H), 6.76 (dd,
J = 0.82, 0.81 Hz, 1H), 3.85 (s, 3H, OCH3). 13C NMR: G 159.6, 145.64,
145.57, 127.3, 126.4, 125.4, 124.5, 117.2, 114.1, 112.3, 107.2, 55.3.
2-(4-Chlorophenyl)imidazo[1,2-a]pyridine (3c): White solid, m.p.
207–209°C (lit.29 201°C); IR Q (cm-1): 2917, 1632, 1471, 1369,
1250, 1202, 1089, 1009, 933, 830, 742, 598, 510. 1H NMR: G 8.09
(d, J = 6.78 Hz, 1H), 7.87 (d, J = 8.52 Hz, 2H), 7.82 (s, 1H), 7.61 (d,
J = 9.15 Hz, 1H), 7.39 (d, J = 8.52 Hz, 2H), 7.17 (t, J = 7.17 Hz, 1H),
6.77 (t, J = 6.60 Hz, 1H). 13C NMR: G 145.7, 144.6, 133.6, 132.3,
128.9, 127.2, 125.6, 124.9, 117.5, 112.6, 108.2.
6-Methyl-2-phenylimidazo[1,2-a]pyridine (3d): White solid, m.p.
171–173°C (lit.6 172–173°C); IR Q (cm-1): 2921, 1628, 1525, 1471,
1418, 1342, 1259, 1206, 1159, 1079, 846, 805, 768, 715, 685, 571,
506. 1H NMR: G 7.95 (d, J = 7.05 Hz, 2H), 7.83 (s, 1H), 7.73 (s, 1H),
7.53 (d, J = 9.09 Hz, 1H), 7.44 (t, J = 6.63 Hz, 2H), 7.33 (d, J = 6.44
Hz, 1H), 7.00 (d, J = 8.82 Hz, 1H). 13C NMR: G 145.4, 144.7, 133.9,
128.7, 127.84, 127.78, 125.9, 123.3, 122.0, 116.7, 107.9, 18.0.
2-(4-Methoxyphenyl)-6-methylimidazo[1,2-a]pyridine (3e): White
solid, m.p. 179–181°C; IR Q (cm-1): 2926, 1612, 1546, 1483, 1413,
1341, 1301, 1246, 1174, 1103, 1023, 839, 794, 744, 710, 591, 528.
1H NMR: G 7.88 (d, J = 2.26 Hz, 2H), 7.86 (d, J = 2.11 Hz, 1H), 7.68
(s, 1H), 7.51 (d, J = 9.48 Hz, 1H), 7.01 (d, J = 1.57 Hz, 2H), 6.96
(dd, J = 2.10, 2.06 Hz, 1H), 3.85 (s, 3H, OCH3), 2.31 (s, 3H, CH3).
13C NMR: G 159.5, 145.3, 144.6, 127.7, 127.2, 126.6, 123.3, 121.9,
116.5, 114.1, 107.0, 55.3, 18.1. MS-ESI: m/z (%): 239 (100). Anal.
Calcd for C15H14N2O: C, 75.61; H, 5.92. Found: C, 75.66; H, 5.85%.
2-(4-Chlorophenyl)-6-methylimidazo[1,2-a]pyridine (3f): White
solid, m.p. 239–240°C (lit.6 240–242°C); IR Q (cm-1): 2921, 1635,
1540, 1465, 1409, 1257, 1206, 1090, 1010, 944, 835, 803, 734, 511.
1H NMR: G 7.89 (d, J = 2.83 Hz, 2H), 7.88 (s, 1H), 7.75 (s, 1H),
7.54 (t, J = 6.05 Hz, 1H), 7.39 (d, J = 8.53 Hz, 2H), 7.05 (d, J = 9.34
Hz, 1H), 2.33 (s, 3H, CH3). 13C NMR: G 144.8, 144.4, 133.5, 132.5,
128.9, 128.1, 127.1, 123.3, 122.3, 116.8, 107.9, 18.1.
Encouraged by our success, we also investigated the
reaction of D-bromoacetophenone with thiourea/thioamide on
grinding at room temperature under catalyst- and solvent-free
conditions. However, the problem in the grinding reaction
is that the starting materials soon become a tough waxy
substance that is hard to grind. To overcome this, we added
three drops of water to the mixture until the substrates form
a paste-like product that was easily ground. And, the process
gave the corresponding product 4-phenylthiazol-2-amine (5a)
as short as 5 min in 94% yield.
Next, we explored the scope and generality of this present
protocol for the synthesis of various 2,4-disubstituted thiazoles
(Table 2). As expected, a variety of D-bromoacetophenone
bearing either electron-donating (Table 2, entries 9–12)
or electron-withdrawing (Table 2, entries 5–8) groups on
aromatic ring underwent smooth transformation to the
corresponding products 5 in excellent yields when they
reacted with thiourea/thioamide. The substitution group
on the phenyl ring did not make any difference in the
reaction. In all cases, the corresponding products were
afforded as short a reaction time as 5 min in excellent yields.
Moreover, the reaction of D-bromo-4-nitroacetophenone with
thioacetamide and thiobenzamide was conducted successfully
in 88% and 92% yields, respectively (Table 2, entries 13–14).
To the best of our knowledge, it was little reported that a
reaction could be conducted within 5 min; except, Kabalka16
reported microwave promoted synthesis of thiazoles.
Compared to the reaction carried out by microwave irradiation,
this procedure is completely free from organic solvents during
the reaction.
,Qꢀ FRQFOXVLRQꢁꢀ ZHꢀ KDYHꢀ GHYHORSHGꢀ Dꢀ VLPSOHꢀ DQGꢀ HI¿FLHQWꢀ
method for the synthesis of imidazo[1,2-a]pyridine and
2,4-disubstituted thiazole derivatives on grinding at room
temperature under catalyst- and solvent-free conditions.
The mildness of the conversion, experimental simplicity,
FRPSDWLELOLW\ꢀZLWKꢀYDULRXVꢀIXQFWLRQDOꢀJURXSVꢁꢀHI¿FLHQWꢀ\LHOGVꢁꢀ
short reaction times, and the easy workup procedure, makes
this procedure attractive to synthesise a variety of these
derivatives.
General procedure for preparation of 5a–n
A mixture of D-bromoketone (1) (1 mmol), thiourea/thioamide (4)
(1 mmol) and three drops of water is ground at room temperature with
a glass pestle in the glass mortar for 5 min. The progress of the reaction
was monitored by TLC. After completion of the reaction, the product
was washed with dehydrated alcohol or ethyl acetate (3ꢀuꢀ10 mL).
The combined organic solvent was removed under vacuum to obtain
WKHꢀFUXGHꢀVROLGꢀSURGXFWꢂꢀ7KHꢀFUXGHꢀSURGXFWꢀZDVꢀIXUWKHUꢀSXUL¿HGꢀE\ꢀ
silica gel column chromatography using ethyl acetate–petroleum
ether as eluent to afford the pure product. The physical and spectra
data of the compounds 5a–n are as follows.
Experimental
&KHPLFDOVꢀ ZHUHꢀ SXUFKDVHGꢀ DQGꢀ XVHGꢀ ZLWKRXWꢀ IXUWKHUꢀ SXUL¿FDWLRQꢂꢀ
All the melting points were uncorrected. 1H NMR and 13C NMR
4-Phenylthiazol-2-amine (5a): White solid, m.p. 150–151°C (Lit.15
150–151°C); IR Q (cm-1): 3432, 2974, 1624, 1524, 1388, 1337, 1045,
670. 1H NMR: G 7.81–7.78 (m, 2H, ArH), 7.42-7.37 (m, 2H, ArH),
7.33–7.28 (m, 1H, ArH), 6.74 (s, 1H, thiazole), 5.05 (br s, 2H, NH2).
13C NMR: G 167.3, 151.3, 134.7, 128.5, 127.7, 126.0, 102.7. MS-EI:
m/z (%): 176 (100), 134 (59), 89 (12).
spectra were measured on
a FT-Bruker AT-300 spectrometer
(1H: 300 MHz, 13C: 75 MHz), using CDCl3 as the solvent with
tetramethylsilane (TMS) as an internal standard at room temperature.
Chemical shifts are given in G relative to TMS, the coupling constants
J are given in Hz. IR spectra was recorded on a AVATAR 370 FI-
IR Spectrophotometer. Mass spectra were measured with Thermo
Finnigan LCQ-Advantage. Elemental analyses were carried out using
a Carlo-Erba EA1112 instrument. Column chromatography was
performed using EM Silica gel 60 (300–400 mesh).
N,4-Diphenylthiazol-2-amine (5b): White solid, m.p. 135–136°C
(Lit.30 135–136°C); IR Q (cm-1): 3432, 2927, 1606, 1562, 1461, 1422,
1310, 692. 1H NMR: G 7.89–7.86 (m, 2H, ArH), 7.60 (s, 1H, ArH),
7.44–7.30 (m, 7H, ArH), 7.10–7.06 (m, 1H, thiazole), 6.84 (br s, 1H,
NH). 13C NMR: G 164.4, 151.3, 140.2, 134.5, 129.3, 128.5, 127.8,
126.0, 122.9, 118.1, 101.7.
General procedure for preparation of 3a–f
A mixture of D-bromoketone (1) (1 mmol), and 2-aminopyridine (2)
(1 mmol) is ground at room temperature with a glass pestle in the
glass mortar. The progress of the reaction was monitored by TLC.
After completion of the reaction, the product was washed with
dehydrated alcohol or ethyl acetate (3ꢀ uꢀ 10 mL). The combined
organic solvent was removed under vacuum to obtain the crude
VROLGꢀSURGXFWꢂꢀ7KHꢀFUXGHꢀSURGXFWꢀZDVꢀIXUWKHUꢀSXUL¿HGꢀE\ꢀVLOLFDꢀJHOꢀ
column chromatography using ethyl acetate–petroleum ether (1:3) as
eluent to afford the pure product. The physical and spectra data of the
compounds 3a–f are as follows.
2-Mmethyl-4-phenylthiazole (5c): White solid, m.p. 67–69°C
(Lit.15 67–68°C); IR Q (cm-1): 3436, 2924, 1640, 1387, 1169, 1028,
676. 1H NMR: G 7.89–7.86 (m, 2H, ArH), 7.42–7.37 (m, 3H, ArH),
7.33–7.27 (m, 1H, ArH), 2.75 (s, 3H, CH3). 13C NMR: G 165.7, 155.1,
134.5, 128.6, 127.8, 126.3, 112.1, 19.2.
2, 4-Diphenylthiazole (5d): White solid, m.p. 90–91°C (Lit.31
91–92°C); IR Q (cm-1): 3435, 2925, 1643, 1519, 1471, 1391, 1058,
673. 1H NMR: G 8.08–8.00 (m, 4H, ArH), 7.49–7.44 (m, 6H, ArH),
7.39–7.37 (m, 1H, thiazole). 13C NMR: G 167.8, 156.3, 134.5, 133.7,
130.0, 128.9, 128.7, 128.2, 126.6, 126.4, 112.6.
2-Phenylimidazo[1,2-a]pyridine (3a): White solid, m.p. 136–
137°C (lit.27 131–133°C); IR Q (cm-1): 2925, 2857, 1738, 1625, 1511,
1460, 1383, 1269, 1201, 1122, 1081, 1040, 744, 688, 458. 1H NMR:
G 8.12 (dd, J = 1.04, 1.03 Hz, 1H), 7.98–7.96 (m, 2H), 7.88 (s, 1H),
7.64 (d, J = 9.14 Hz, 1H), 7.45 (t, J = 7.22 Hz, 2H), 7.35 (d, J = 7.33
Hz, 1H), 7.20–7.17 (m, 1H), 6.79 (d, J = 6.78 Hz, 1H). 13C NMR:
G 145.8, 145.7, 133.8, 128.7, 127.9, 126.0, 125.6, 124.6, 117.5, 112.4,
108.1. MS-ESI: m/z (%): 195 (100).
4-(4-Chlorophenyl)thiazol-2-amine (5e): White solid, m.p.
167–168°C (Lit.15 163–164°C); IR Q (cm-1): 3433, 2924, 1628,
1532, 1466, 1395, 1041, 730. 1H NMR: G 7.74–7.70 (m, 2H, ArH),
7.38–7.33 (m, 2H, ArH), 6.73 (s, 1H, thiazole), 5.07 (br s, 2H, NH2).
13C NMR: G 167.3, 150.2, 133.4, 133.1, 128.8, 127.3, 103.3.
4-(4-Chlorophenyl)-N-phenylthiazol-2-amine (5f): White solid,
m.p. 144–146°C; IR Q (cm-1): 3383, 2974, 1559, 1473, 1399, 1304,